NEW YORK, Jan. 9 /PRNewswire-FirstCall/ -- American Oriental Bioengineering, Inc. , a leading manufacturer and distributor of plant-based pharmaceutical and nutraceutical products in China, today announced the national launch in China of Jinji Yi Mu Cau, a dissolving powder pill designed to regulate the menstrual cycle and alleviate pre-menstrual cycle pain, which the Company believes impacts over 250 million women in China each year. Jinji Yi Mu Cau is part of the Jinji family of products that was acquired through the Company's purchase of GLP in April 2006. AOB plans to significantly broaden the exposure of this product throughout China via its large distribution network as well as through a focused, nationwide marketing campaign.
The Company will kick off the new product launch at its sales conference in mid-January 2007 when AOB management will meet with product distributors from all over China to discuss the new marketing plan for the product and allow distributors to place orders. A nationwide television campaign for the Jinji Yi Mu Cau product will commence at the same time as the sales conference. AOB expects this product to be available across the Company's distribution network in the first half of the first quarter 2007.
Tony Liu, Chairman and Chief Executive Officer of AOB commented, "We are pleased to announce the launch of Jinji Yi Mu Cau and believe the nationwide introduction of this product furthers our position as a leading brand in women's health throughout China. This new product is an important extension to our Jinji line and reflects the ongoing product opportunities we are deriving from the acquisition of GLP. We expect the addition of Jinji Yi Mu Cau into our large distribution network to drive strong product volume and establish an additional stream of recurring revenue for our business."
Tony Liu continued, "We believe the market opportunity for the Jinji Yi Mu Cau dissolving powder pill is a very compelling opportunity for our business and one that will continue to grow in the coming years. Jinji Yi Mu Cau is covered by the PRC's social health insurance system, so it is affordable and accessible to a large number of Chinese women who have irregular menstrual cycles and endure pre-menstrual pain. We believe our brand strength and ability to scale new products across our established distribution network will continue to uniquely position our business for continued growth in the current fiscal year and beyond."
About American Oriental Bioengineering Inc.
American Oriental Bioengineering Inc. (AOB) is engaged in the development and production of plant-based pharmaceutical products and plant-based nutraceutical products widely distributed throughout China. For more information, visit http://www.bioaobo.com.
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, fluctuations in operating results and other risks contained in reports filed from time to time with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
American Oriental Bioengineering, Inc.CONTACT: Ashley M. Ammon or Bill Zima, Integrated Corporate Relations,Inc., +1-203-682-8200
Web site: http://www.bioaobo.com/
